statistiche ricercatore

RIVA, NICOLETTA

Distribuzione geografica

Continente	#
NA - Nord America	2.349
EU - Europa	863
AS - Asia	724
SA - Sud America	74
Continente sconosciuto - Info sul continente non disponibili	51
AF - Africa	13
OC - Oceania	4
Totale	4.078

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	2.313
IT - Italia	462
SG - Singapore	215
CN - Cina	172
UA - Ucraina	105
VN - Vietnam	99
TR - Turchia	95
HK - Hong Kong	85
BR - Brasile	55
SE - Svezia	54
DE - Germania	48
GB - Regno Unito	40
IE - Irlanda	40
FR - Francia	35
RU - Federazione Russa	29
BD - Bangladesh	22
CA - Canada	19
FI - Finlandia	16
AR - Argentina	8
IN - India	8
MX - Messico	8
HR - Croazia	7
NL - Olanda	6
PL - Polonia	6
PK - Pakistan	5
AU - Australia	4
CO - Colombia	4
AT - Austria	3
CL - Cile	3
EG - Egitto	3
IQ - Iraq	3
JP - Giappone	3
LT - Lituania	3
PH - Filippine	3
ZA - Sudafrica	3
AE - Emirati Arabi Uniti	2
CH - Svizzera	2
EC - Ecuador	2
ID - Indonesia	2
JM - Giamaica	2
MY - Malesia	2
NG - Nigeria	2
SA - Arabia Saudita	2
SV - El Salvador	2
UZ - Uzbekistan	2
AL - Albania	1
BE - Belgio	1
BO - Bolivia	1
BS - Bahamas	1
CR - Costa Rica	1
CZ - Repubblica Ceca	1
DZ - Algeria	1
ES - Italia	1
ET - Etiopia	1
GR - Grecia	1
GT - Guatemala	1
IL - Israele	1
KE - Kenya	1
LB - Libano	1
LY - Libia	1
MA - Marocco	1
MD - Moldavia	1
OM - Oman	1
PA - Panama	1
RO - Romania	1
TH - Thailandia	1
TT - Trinidad e Tobago	1
VE - Venezuela	1
Totale	4.027

Salva come PNG Salva come JPEG

Città	#
Milan	329
Fairfield	236
Woodbridge	201
San Jose	185
Ashburn	183
Ann Arbor	142
Houston	134
Singapore	128
Dallas	118
Chandler	96
Cambridge	90
Wilmington	90
Jacksonville	88
Seattle	87
Hong Kong	83
Council Bluffs	66
The Dalles	51
Izmir	48
Princeton	41
Beijing	40
Dublin	36
Ho Chi Minh City	30
Dearborn	29
Boardman	26
Nyköping	26
Lauterbourg	22
Rome	21
Chicago	20
Los Angeles	19
Santa Clara	19
London	16
New York	16
Dong Ket	15
Hanoi	15
Washington	13
San Diego	11
Guangzhou	10
Shanghai	10
Ogden	9
Nuremberg	8
Como	7
Mexico City	7
Zagreb	7
Boston	6
Hefei	6
Montreal	6
Naples	6
Tianjin	6
Warsaw	6
Düsseldorf	5
Hangzhou	5
North Bergen	5
Toronto	5
Chennai	4
Columbus	4
Denver	4
Frankfurt am Main	4
Newark	4
Norwalk	4
Shenzhen	4
Brooklyn	3
Dhaka	3
Haiphong	3
Jinan	3
Nanchang	3
Nanjing	3
Orem	3
Redwood City	3
San Mateo	3
Shibin al Kawm	3
São Paulo	3
Abuja	2
Atlanta	2
Belfast	2
Berlin	2
Besana In Brianza	2
Biên Hòa	2
Campinas	2
Catania	2
Cavaria con Premezzo	2
Changsha	2
Charlotte	2
Dalian	2
Elk Grove Village	2
Helsinki	2
Honolulu	2
Lahore	2
Las Vegas	2
Martinengo	2
Medellín	2
Ottawa	2
Panama City	2
Philadelphia	2
Portal	2
Prescot	2
Quzhou	2
Quận Năm	2
San Francisco	2
San Salvador	2
Santa Fe	2
Totale	3.003

Salva come PNG Salva come JPEG

Nome	#
Direct oral anticoagulants in atrial fibrillation: can data from randomized clinical trials be safely transferred to the general population? Yes	318
Clinical history and antithrombotic treatment of incidentally detected splanchnic vein thrombosis: a multicentre, international prospective registry	266
Cangrelor for the treatment of arterial thrombosis: pharmacokinetics/pharmacodynamics and clinical data	227
Major Bleeding and Case Fatality Rate with the Direct Oral Anticoagulants in Orthopedic Surgery: A Systematic Review and Meta-Analysis	222
Pros and cons of vitamin K antagonists and non-vitamin K antagonist oral anticoagulants	221
Statin use and bleeding risk during vitamin K antagonist treatment for venous thromboembolism: A multicenter retrospective cohort study	216
Recurrent Thrombotic Events after Discontinuation of Vitamin K Antagonist Treatment for Splanchnic Vein Thrombosis: A Multicenter Retrospective Cohort Study	214
Epidemiology and pathophysiology of venous thromboembolism: similarities with atherothrombosis and the role of inflammation	206
Prevalence of renal failure and use of antithrombotic prophylaxis among medical inpatients at increased risk of venous thromboembolic events.	199
Poor predictive value of contemporary bleeding risk scores during long-term treatment of venous thromboembolism: A multicentre retrospective cohort study	189
Efficacy and safety of the novel oral anticoagulants in atrial fibrillation: a systematic review and meta-analysis of the literature.	174
Multiple overlapping systematic reviews facilitate the origin of disputes: the case of thrombolytic therapy for pulmonary embolism	159
Portal vein thrombosis in decompensated cirrhosis: rationale for treatment	159
Which patients with venous thromboembolism should receive non-vitamin k antagonist oral anticoagulants? The majority	148
Stroke: Patients with CVT urgently need high-quality evidence	128
Recommendations from the ICM-VTE: General	127
Clinical history of cancer-associated splanchnic vein thrombosis	123
Rivaroxaban for the treatment of noncirrhotic splanchnic vein thrombosis: an interventional prospective cohort study.	112
Estimating Bleeding Risk in Patients with Cancer-Associated Thrombosis: Evaluation of Existing Risk Scores and Development of a New Risk Score	101
Diagnostic accuracy of D-dimer in patients at high-risk for splanchnic vein thrombosis: A systematic review and meta-analysis	100
Changes in the landscape of anticoagulation: a focus on direct oral anticoagulants	99
Mitigating Disputes Originated by Multiple Discordant Systematic Reviews and Meta-Analyses: A Survey of Methodologists and Clinicians	89
Diagnostic accuracy of V/Q and Q SPECT/CT in patients with suspected pulmonary embolism: a systematic review and meta-analysis	88
The effect of DOAC-Stop® on several oral and parenteral anticoagulants	73
Anticoagulant therapy for splanchnic vein thrombosis: an individual patient data meta-analysis	60
Trials of interventions for ovarian and testicular germ cell tumors registered in ClinicalTrials.gov: A cross-sectional study	60
Totale	4.078

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	17.719
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	17.719

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	131	0	0	0	2	7	12	6	9	4	50	17	24
2022/2023	257	21	8	28	18	21	54	3	41	40	9	4	10
2023/2024	559	90	90	80	106	118	51	0	2	10	9	0	3
2024/2025	384	3	3	56	12	17	46	26	18	19	52	45	87
2025/2026	969	74	61	108	94	72	61	216	59	88	71	40	25
2026/2027	256	29	34	122	71	0	0	0	0	0	0	0	0
Totale													4.078